[18F]-2-[(2S,5R,8S,11S)-8-[4-[[4-[(5-fluoro-3,7-dioxo-4,6-dioxa-1,9,12-triaza-5-aluminabicyclo[7.5.2]hexadecan-12-yl)methyl]phenyl]carbamothioylamino]butyl]-11-(3-guanidinopropyl)-5-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid

ID: ALA2153500

Chembl Id: CHEMBL2153500

PubChem CID: 71462035

Max Phase: Preclinical

Molecular Formula: C45H63AlFN13O12S

Molecular Weight: 1056.12

Molecule Type: Protein

Associated Items:

Names and Identifiers

Canonical SMILES:  N=C(N)NCCC[C@@H]1NC(=O)[C@H](CCCCNC(=S)Nc2ccc(CN3CCN4CCN(CC3)CC(=O)O[Al]([18F])OC(=O)C4)cc2)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(=O)O)NC(=O)CNC1=O

Standard InChI:  InChI=1S/C45H65N13O12S.Al.FH/c46-44(47)48-15-3-5-32-40(67)50-24-36(60)52-35(23-37(61)62)43(70)55-34(22-28-8-12-31(59)13-9-28)42(69)54-33(41(68)53-32)4-1-2-14-49-45(71)51-30-10-6-29(7-11-30)25-56-16-18-57(26-38(63)64)20-21-58(19-17-56)27-39(65)66;;/h6-13,32-35,59H,1-5,14-27H2,(H,50,67)(H,52,60)(H,53,68)(H,54,69)(H,55,70)(H,61,62)(H,63,64)(H,65,66)(H4,46,47,48)(H2,49,51,71);;1H/q;+3;/p-3/t32-,33-,34+,35-;;/m0../s1/i;;1-1

Standard InChI Key:  RTFGRBATOBEMID-IMKWQKIPSA-K

Associated Targets(Human)

Serum (1292 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Blood (1764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Muscle (539 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pancreas (361 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Heart (1016 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Lung (1108 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver (8163 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Spleen (906 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Stomach (551 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Intestine (514 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Kidney (1278 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bone (344 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bladder (50 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1056.12Molecular Weight (Monoisotopic): 1055.4239AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Shetty D, Jeong JM, Kim YJ, Lee JY, Hoigebazar L, Lee YS, Lee DS, Chung JK..  (2012)  Development of a bifunctional chelating agent containing isothiocyanate residue for one step F-18 labeling of peptides and application for RGD labeling.,  20  (19): [PMID:22917858] [10.1016/j.bmc.2012.07.050]

Source